Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)vsHenry Schein Inc (HSIC)
HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
$0.49
-2.06%
HEALTHCARE · Cap: $9.28M
HSIC
Henry Schein Inc
$77.45
+1.51%
HEALTHCARE · Cap: $9.26B
Smart Verdict
WallStSmart Research — data-driven comparison
Henry Schein Inc generates 81710% more annual revenue ($13.38B vs $16.36M). HSIC leads profitability with a 3.0% profit margin vs -4.3%. HSIC earns a higher WallStSmart Score of 52/100 (C-).
HKPD
Avoid27
out of 100
Grade: F
HSIC
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HKPD.
Margin of Safety
+46.8%
Fair Value
$153.40
Current Price
$77.45
$75.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 3.0%
Weak financial health signals
ROE of -17.2% — below average capital efficiency
Expensive relative to growth rate
4.5% earnings growth
3.0% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : HKPD
The strongest argument for HKPD centers on Price/Book, Altman Z-Score.
Bull Case : HSIC
The strongest argument for HSIC centers on Price/Book.
Bear Case : HKPD
The primary concerns for HKPD are Market Cap, Operating Margin, Piotroski F-Score.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, EPS Growth, Profit Margin. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
HKPD profiles as a turnaround stock while HSIC is a value play — different risk/reward profiles.
HSIC is growing revenue faster at 6.3% — sustainability is the question.
HKPD generates stronger free cash flow (-106,393), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HSIC scores higher overall (52/100 vs 27/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.
Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?